Considering the dangers of advanced AI and AI-enhanced social media, there is an urgent need to design neuroscience-based policies to support citizens in building a system of digital self-defense. Enter the “Neuroshield.”
"Creating a global norm for PPA transparency is a zero-cost step to help provide energy for everyone and deliver on the low carbon future we all need," write the authors. Read their post about power purchase agreements on the Baker Institute Blog.
This article originally appeared in the Forbes blog on June 1, 2022.
An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.
"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.
U.S. National Security Advisor John Bolton recently remarked that Brazil's newly elected president, Jair Bolonsoro, is a “like-minded” leader for the Trump administration. In a blog for Axios, nonresident fellow Christopher Sabatini reviews these comments and the right-wing authoritarian style of Bolsonaro: https://bit.ly/2EYT9od